Rankings
▼
Calendar
CRMD Q4 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$55,713
+124.8% YoY
Gross Profit
-$1,520
-2.7% margin
Operating Income
-$6M
-10921.4% margin
Net Income
-$6M
-10925.5% margin
EPS (Diluted)
$-0.19
QoQ Revenue Growth
-40.1%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$516,176
Balance Sheet
Total Assets
$49M
Total Liabilities
$5M
Stockholders' Equity
$44M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$55,713
$24,779
+124.8%
Gross Profit
-$1,520
-$21,346
+92.9%
Operating Income
-$6M
-$5M
-13.2%
Net Income
-$6M
-$5M
-14.7%
← FY 2020
All Quarters
Q1 2021 →